Expression of Histone Deacetylases in Diffuse Large B-cell Lymphoma and Its Clinical Significance

Background: Histone deacetylase inhibitors are a new class of drugs used in treatment of malignant tumors. Diffuse large B-cell lymphoma (DLBCL) is the most common type of B-cell lymphoma, and it accounts for more than 40% of all B-cell lymphomas. In this study, we aimed to determine the expression...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lee, Sung Hak, Yoo, Changyoung, Im, Soyoung, Jung, Ji-Han, Choi, Hyun Joo, Yoo, Jinyoung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2014
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4115238/
https://ncbi.nlm.nih.gov/pubmed/25076845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.8522
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak